Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
Top Cited Papers
- 1 March 2003
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 361 (9363), 1077-1083
- https://doi.org/10.1016/s0140-6736(03)12892-9
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACHInternational Journal of Cardiology, 2002
- Ventricular assist device in severe heart failure. Effects on cytokines, complement and body weightPublished by Oxford University Press (OUP) ,2001
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failureEuropean Heart Journal, 1999
- Elevated soluble CD14 receptors and altered cytokines in chronic heart failureThe American Journal of Cardiology, 1997
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- EFFECTS OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL ON BACTERIAL TRANSLOCATION AFTER THERMAL INJURY AND BACTERIAL CHALLENGEShock, 1996
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failureJournal of the American College of Cardiology, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990